Your browser doesn't support javascript.
loading
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
Hellmann, Matthew D; Callahan, Margaret K; Awad, Mark M; Calvo, Emiliano; Ascierto, Paolo A; Atmaca, Akin; Rizvi, Naiyer A; Hirsch, Fred R; Selvaggi, Giovanni; Szustakowski, Joseph D; Sasson, Ariella; Golhar, Ryan; Vitazka, Patrik; Chang, Han; Geese, William J; Antonia, Scott J.
Afiliação
  • Hellmann MD; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY 10017, USA. Electronic address: hellmanm@mskcc.org.
  • Callahan MK; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY 10017, USA.
  • Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Calvo E; START Madrid, Centro Integral Oncológico Clara Campal, Medical Oncology Division, Hospital Universitario Madrid Norte Sanchinarro, Madrid 28050, Spain.
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples 80131, Italy.
  • Atmaca A; Department of Hematology and Oncology, Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main 60488, Germany.
  • Rizvi NA; Division of Hematology and Oncology, Columbia University Medical Center, New York, NY 10032, USA.
  • Hirsch FR; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Selvaggi G; Clinical Development, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Szustakowski JD; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Sasson A; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Golhar R; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Vitazka P; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Chang H; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Geese WJ; Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Antonia SJ; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Cancer Cell ; 33(5): 853-861.e4, 2018 05 14.
Article em En | MEDLINE | ID: mdl-29731394
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Ipilimumab / Nivolumabe / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Ipilimumab / Nivolumabe / Neoplasias Pulmonares / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article